Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment 인슐린 에프시토라 알파(에프시토라)는 주 1회 투여하도록 설계된 새로운 기저 인슐린입니다.
Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment Insulin efsitora alfa (efsitora) is a new basal insulin designed for once-weekly administration. Data on safety and efficacy have been limited to small, phase 1 or phase 2 … Continued